Category: Zacks Small Cap Research

123458830 / 874 POSTS
By John Vandermosten, CFANASDAQ:ACHV On Monday, Achieve Life Sciences, Inc. (NASDAQ:ACHV) updated the investment community on the status of New Zealand’s RAUORA1 study, which was expected to announce completion in the months leading up to the Se ...
By David Bautz, PhDNASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 DOM-INNATE Trial Fully Enrolled On June 24, 2020, Soligenix, Inc. (NASDAQ:SNGX) announced that enrollment has completed in the Phase 3 DOM-INNATE (Dusquetide tr ...
By Ian Gilson, PhD, CFANASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio (NASDAQ:MBII) has announced that Regalia is the leading biofungicide in California, with a market share of over 25% in the leaf biofungicide treatment market, for the J ...
By John Vandermosten, CFATSX:HBP.TO On June 23, 2020, Proactive hosted its One2One Virtual Forum, featuring several biotech company updates on their clinical programs. Presenting on behalf of Helix BioPharma (TSX:HBP.TO) was Dr. Heman Chao, CEO and D ...
By Anita Dushyanth, PhDNASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer’s disease Both scientists and physicians are still wrestling with the idea of how to identify the biological drivers that are responsible for the ...
By David Bautz, PhDNASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Update on Vaccine Programs On June 16, 2020, Soligenix Inc. (NASDAQ:SNGX) Senior Vice President and Chief Scientific Officer, Dr. Oreola Donini, presented at the MedInv ...
By M. MarinNASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Contract Validates Potential of HemoDefend Technology Cytosorbents (NASDAQ:CTSO) was awarded a Defense Health Agency Small Business Technology Transfer (STTR) Phase III contract valued at up t ...
By M. MarinNASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), a clinical-stage pharmaceutical company with a proprietary oral protein delivery platform technology, presented preliminary data findings from its NA ...
By John Vandermosten, CFANASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT Initiating Coverage Novan, Inc. (NASDAQ:NOVN) is currently pursuing an indication in molluscum contagiosum (MC), a contagious skin condition that generally affects young childr ...
By John Vandermosten, CFATSX:PMN.TO | OTC:ARFXF Neurodegenerative diseases continue to afflict millions of people worldwide and effective therapies have remained elusive. The best known, most prevalent neurodegenerative pathosis is Alzheimer’s Diseas ...
123458830 / 874 POSTS